Literature DB >> 22450307

Techniques used to characterize the gut microbiota: a guide for the clinician.

Marianne H Fraher1, Paul W O'Toole, Eamonn M M Quigley.   

Abstract

The gut microbiota is a complex ecosystem that has a symbiotic relationship with its host. An association between the gut microbiota and disease was first postulated in the early 20(th) century. However, until the 1990s, knowledge of the gut microbiota was limited because bacteriological culture was the only technique available to characterize its composition. Only a fraction (estimated at <30%) of the gut microbiota has been cultured to date. Since the 1990s, advances in culture-independent techniques have spearheaded our knowledge of the complexity of this ecosystem. These techniques have elucidated the microbial diversity of the gut microbiota and have shown that alterations in the gut microbiota composition and function are associated with certain disease states, such as IBD and obesity. These new techniques are fast, facilitate high throughput, identify organisms that are uncultured to date and enable enumeration of organisms present in the gut microbiota. This Review discusses the techniques that can used to characterize the gut microbiota, when they can be applied to human studies and their relative advantages and limitations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450307     DOI: 10.1038/nrgastro.2012.44

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  86 in total

Review 1.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

2.  Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly.

Authors:  Jutta Zwielehner; Kathrin Liszt; Michael Handschur; Cornelia Lassl; Alexander Lapin; Alexander G Haslberger
Journal:  Exp Gerontol       Date:  2009-04-17       Impact factor: 4.032

3.  A sequencing method based on real-time pyrophosphate.

Authors:  M Ronaghi; M Uhlén; P Nyrén
Journal:  Science       Date:  1998-07-17       Impact factor: 47.728

4.  Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?

Authors:  Keith L E Dear; Marinos Elia; John O Hunter
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 5.  The role of probiotic cultures in the prevention of colon cancer.

Authors:  L J Brady; D D Gallaher; F F Busta
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

6.  Towards the human intestinal microbiota phylogenetic core.

Authors:  Julien Tap; Stanislas Mondot; Florence Levenez; Eric Pelletier; Christophe Caron; Jean-Pierre Furet; Edgardo Ugarte; Rafael Muñoz-Tamayo; Denis L E Paslier; Renaud Nalin; Joel Dore; Marion Leclerc
Journal:  Environ Microbiol       Date:  2009-07-06       Impact factor: 5.491

Review 7.  Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshimi Benno; Osamu Kanauchi; Yoshihide Fujiyama
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

Authors:  Samah O Noor; Karyn Ridgway; Louise Scovell; E Katherine Kemsley; Elizabeth K Lund; Crawford Jamieson; Ian T Johnson; Arjan Narbad
Journal:  BMC Gastroenterol       Date:  2010-11-12       Impact factor: 3.067

9.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

Review 10.  The environment within: how gut microbiota may influence metabolism and body composition.

Authors:  A Vrieze; F Holleman; E G Zoetendal; W M de Vos; J B L Hoekstra; M Nieuwdorp
Journal:  Diabetologia       Date:  2010-01-26       Impact factor: 10.122

View more
  113 in total

Review 1.  The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models-Part I: Overview of Current Methods.

Authors:  Riley L Hughes; Maria L Marco; James P Hughes; Nancy L Keim; Mary E Kable
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

Review 2.  The microbiome: stress, health and disease.

Authors:  Rachel D Moloney; Lieve Desbonnet; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Mamm Genome       Date:  2013-11-27       Impact factor: 2.957

Review 3.  Pancreatic cancer, inflammation, and microbiome.

Authors:  Constantinos P Zambirinis; Smruti Pushalkar; Deepak Saxena; George Miller
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 4.  Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions.

Authors:  Edmund B Chen; Cori Cason; Jack A Gilbert; Karen J Ho
Journal:  J Gastrointest Surg       Date:  2018-04-05       Impact factor: 3.452

Review 5.  Gut microbiota: its role in hepatic encephalopathy.

Authors:  Rahul Rai; Vivek A Saraswat; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-16

Review 6.  Recent Advancements in Intestinal Microbiota Analyses: A Review for Non-Microbiologists.

Authors:  Xiao-Wei Feng; Wen-Ping Ding; Ling-Yun Xiong; Liang Guo; Jia-Ming Sun; Peng Xiao
Journal:  Curr Med Sci       Date:  2018-12-07

Review 7.  Application of in vitro gut fermentation models to food components: A review.

Authors:  Jin Seok Moon; Ling Li; Jeongsu Bang; Nam Soo Han
Journal:  Food Sci Biotechnol       Date:  2016-03-31       Impact factor: 2.391

Review 8.  Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour.

Authors:  John F Cryan; Timothy G Dinan
Journal:  Nat Rev Neurosci       Date:  2012-09-12       Impact factor: 34.870

Review 9.  Deciphering the tête-à-tête between the microbiota and the immune system.

Authors:  Neeraj K Surana; Dennis L Kasper
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

10.  Transplantation-associated long-term immunosuppression promotes oral colonization by potentially opportunistic pathogens without impacting other members of the salivary bacteriome.

Authors:  Patricia I Diaz; Bo-Young Hong; Jorge Frias-Lopez; Amanda K Dupuy; Mark Angeloni; Loreto Abusleme; Evimaria Terzi; Effie Ioannidou; Linda D Strausbaugh; Anna Dongari-Bagtzoglou
Journal:  Clin Vaccine Immunol       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.